诺诚健华：2025年第一季度净利润1796.76万元

Core Insights - The company reported a total revenue of 381 million yuan in Q1 2025, representing a year-on-year increase of 129.92% [1] - Pharmaceutical sales revenue reached approximately 311.67 million yuan, showing a growth of 89.11% compared to the previous year [1] - The net profit for Q1 2025 was 17.97 million yuan, a significant turnaround from a net loss of 142 million yuan in the same period last year [1] - As of March 31, 2025, the company held cash and cash equivalents of about 7.78 billion yuan [1]